Toward Targeted Therapies for Autoimmune Disorders

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

AUTOIMMUNE TARGETS: This false-color transmission electron micrograph (TEM) displays a slice through a mammalian pancreatic islet cell, the target of an aberrant immune response in type 1 diabetes patients. The red spots in white spaces are membrane-bound secretory granules containing insulin and other hormones to be excreted into the blood. (Nucleus, upper right.)© SPL/SCIENCE SOURCE

History often repeats itself. More than 100 years ago, one of the world’s leading immunologists, Nobel Laureate Paul Ehrlich, doubted the very existence of autoimmunity, in which the immune system begins to attack healthy tissues. Envisioning a nightmare scenario where the body turns against itself, Ehrlich reasoned that it would be quite improbable. His skepticism regarding this phenomenon, which he termed “horror autotoxicus” (literally, “the horror of self-toxicity”), delayed the acceptance of this concept for another half century—even in the face of compelling clinical examples of immunity gone haywire.

A century of basic research later, scientists now accept that autoimmunity does in fact exist, with devastating consequences. More than 20 autoimmune diseases have been identified; these disorders affect every organ in the body and afflict ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Lawrence Steinman

    This person does not yet have a bio.

Published In

June 2016

Found in Translation

Some supposedly nonfunctional RNA molecules encode functional peptides

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio